↓ Skip to main content

Axitinib as a third or further line of treatment in renal cancer: a single institution experience

Overview of attention for article published in BMC Urology, June 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
9 Mendeley